EP
PFE icon

Elkhorn Partners’s Pfizer PFE Stock Holding History

Elkhorn Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Buy
7,400
+400
+6% +$10.6K 0.13% 19
2025
Q4 		$174K Sell
7,000
-3,800
-35% -$95.8K 0.11% 20
2025
Q3 		$275K Hold
10,800
– – 0.19% 18
2025
Q2 		$262K Sell
10,800
-200
-2% -$4.66K 0.19% 19
2025
Q1 		$279K Buy
11,000
+1,500
+16% +$39.3K 0.18% 18
2024
Q4 		$252K Buy
9,500
+3,400
+56% +$92.2K 0.17% 17
2024
Q3 		$177K Sell
6,100
-900
-13% -$26.3K 0.11% 20
2024
Q2 		$196K Buy
7,000
+1,600
+30% +$44K 0.14% 21
2024
Q1 		$150K Buy
5,400
+1,500
+38% +$41.6K 0.11% 23
2023
Q4 		$112K Sell
3,900
-1,400
-26% -$42.3K 0.08% 25
2023
Q3 		$176K Buy
5,300
+700
+15% +$24.8K 0.12% 23
2023
Q2 		$169K Buy
4,600
+400
+10% +$15.6K 0.11% 24
2023
Q1 		$171K Buy
+4,200
New +$181K 0.11% 22

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Elkhorn Partners's PFE Position: Q1 2026 in Review

Elkhorn Partners increased its Pfizer (PFE) stake by 5.7% in Q1 2026, buying an estimated $10.6K and bringing the position to 7,400 shares worth $208K. The position accounts for 0.13% of the portfolio, ranked #19.

Elkhorn Partners first reported a position in PFE in Q1 2023 and has held it in 13 quarters since. The position peaked at $279K in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Elkhorn Partners held 7,400 shares of Pfizer worth $208K as of Q1 2026.
  • Elkhorn Partners bought 400 Pfizer shares in Q1 2026, an estimated $10.6K.
  • Pfizer made up 0.13% of Elkhorn Partners's portfolio in Q1 2026, its #19 holding.
  • Elkhorn Partners first reported a position in Pfizer in Q1 2023 and has held it in 13 quarters since.
  • Elkhorn Partners's Pfizer position peaked at $279K in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Elkhorn Partners's 13F filing for Q1 2026, filed 14 May 2026.